guaifenesin 400 MG / phenylephrine hydrochloride 10 MG Oral Tablet
- RxCUI
- 1304111
- RxNorm name
- guaifenesin 400 MG / phenylephrine hydrochloride 10 MG Oral Tablet
- Display name
- guaiFENesin/Phenylephrine (Oral Pill)
- Full name
- guaifenesin 400 MG / phenylephrine hydrochloride 10 MG Oral Tablet
- Term type
- SCD
- Status
- Active
- Strength
- 400-10 mg
- Dose form
- Tab
- Route
- Oral Pill
- Updated
- 2026-11-16 14:56:12
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 092012
- Active start
- 092012
- Multiple ingredient
- YES
- Branded
- NO
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| guaifenesin | 400 MG / 1 EACH | guaifenesin | guaifenesin |
| phenylephrine hydrochloride | 10 MG / 1 EACH | phenylephrine | phenylephrine hydrochloride |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Oral Tablet | 317541 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| guaifenesin | 5032 |
| phenylephrine | 8163 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | guaiFENesin 400 MG / phenylephrine hydrochloride 10 MG Oral Tablet | 1 | NAMES |
| RxNorm Name | guaifenesin 400 MG / phenylephrine hydrochloride 10 MG Oral Tablet | 1 | NAMES |
| TTY | SCD | 1 | ATTRIBUTES |
| SPL_SET_ID | 13 linked values
| 13 | CODES |
| RxCUI | 1304111 | 1 | CODES |
| MMSL_CODE | 2 | CODES |
FDA NDC Products And Packages#
| Package NDC | Product NDC | Name | Labeler | Application |
|---|---|---|---|---|
| 0363-0542-01 | 0363-0542 | Mucus Relief PE Guaifenesin, Phenylephrine HCl | Walgreen Company | M012 |
| 0536-1309-07 | 0536-1309 | Rugby Chest Congestion Relief Guaifenesin/phenylephrine | Rugby Laboratories | M012 |
| 0536-1309-08 | 0536-1309 | Rugby Chest Congestion Relief Guaifenesin/phenylephrine | Rugby Laboratories | M012 |
| 36800-989-50 | 36800-989 | Topcare Chest Congestion and Sinus Congestion Relief PE Guaifenesin/phenylephrine | TOPCO ASSOCIATES LLC | M012 |
| 46122-700-71 | 46122-700 | GNP Mucus Relief Guaifenesin/phenylephrine | AmerisourceBergen Drug Corp | M012 |
| 49348-774-09 | 49348-774 | Sunmark Chest Congestion Relief PE Guaifenesin/phenylephrine | Strategic Sourcing Services LLC | M012 |
| 63941-986-50 | 63941-986 | Always Save Mucus Relief Guaifenesin/phenylephrine | Valu Merch | M012 |
| 69842-997-60 | 69842-997 | CVS Health Chest Congestion Relief PE Guaifenesin/phenylephrine | CVS Pharmacy, Inc. | M012 |
| 70000-0141-1 | 70000-0141 | Mucus Relief PE Sinus Congestion Guaifenesin, Phenylephrine HCl | Cardinal Health 110, LLC. DBA Leader | M012 |
| 70677-1056-1 | 70677-1056 | Foster and Thrive Chest Congestion Relief PE Guaifenesin/phenylephrine | Strategic Sourcing Services LLC | M012 |
| 73057-389-04 | 73057-389 | Pharbinex-PE GUAIFENESIN 400mg and PHENYLEPHRINE HCL 10MG | Ulai Health LLC | M012 |
Drugs@FDA Applications#
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| cb1c1922-5dc6-520d-e77e-e951726d9701 | guaiFENesin 400 MG / phenylephrine HCl 10 MG Oral Tablet [PSN] · guaifenesin 400 MG / phenylephrine hydrochloride 10 MG Oral Tablet [SCD] | 2 | 18 | Walgreens 44-542 | 20250818 |
| b9129c7b-c869-436f-ab95-269610ef2d9f | guaiFENesin 400 MG / phenylephrine HCl 10 MG Oral Tablet [PSN] · guaifenesin 400 MG / phenylephrine hydrochloride 10 MG Oral Tablet [SCD] | 2 | 14 | Leader 44-542 | 20251009 |
| 3429aedc-e83d-498a-bfca-03aaf5847b3b | guaiFENesin 400 MG / phenylephrine HCl 10 MG Oral Tablet [PSN] · guaifenesin 400 MG / phenylephrine hydrochloride 10 MG Oral Tablet [SCD] | 2 | 10 | DRUG FACTS | 20260115 |
| 5fb7ceb4-97da-4aa5-baa4-9eb2778ee2f6 | guaiFENesin 400 MG / phenylephrine HCl 10 MG Oral Tablet [PSN] · guaifenesin 400 MG / phenylephrine hydrochloride 10 MG Oral Tablet [SCD] | 2 | 9 | DRUG FACTS | 20241217 |
| 2fb83580-7fe1-41a5-abf6-0dc25520f260 | guaiFENesin 400 MG / phenylephrine HCl 10 MG Oral Tablet [PSN] · guaifenesin 400 MG / phenylephrine hydrochloride 10 MG Oral Tablet [SCD] | 2 | 5 | DRUG FACTS | 20241218 |
| 63932e68-b09d-4500-bc1d-cfb2c267df1c | guaiFENesin 400 MG / phenylephrine HCl 10 MG Oral Tablet [PSN] · guaifenesin 400 MG / phenylephrine hydrochloride 10 MG Oral Tablet [SCD] | 2 | 4 | DRUG FACTS | 20241218 |
| f94ae469-4c79-4ce9-9a3d-3bdc645be6d9 | guaiFENesin 400 MG / phenylephrine HCl 10 MG Oral Tablet [PSN] · guaifenesin 400 MG / phenylephrine hydrochloride 10 MG Oral Tablet [SCD] | 2 | 4 | DRUG FACTS | 20241218 |
| 31257238-a0b0-4f2c-98ea-c24b8a6dc30a | guaiFENesin 400 MG / phenylephrine HCl 10 MG Oral Tablet [PSN] · guaifenesin 400 MG / phenylephrine hydrochloride 10 MG Oral Tablet [SCD] | 2 | 4 | Major 44-542 | 20191101 |
| e459bb83-b1d6-42fc-aa46-99ad117e6144 | guaiFENesin 400 MG / phenylephrine HCl 10 MG Oral Tablet [PSN] · guaifenesin 400 MG / phenylephrine hydrochloride 10 MG Oral Tablet [SCD] | 2 | 3 | Drug Facts | 20250120 |
| a49020e8-739e-47ec-8141-e866479a3ab3 | guaiFENesin 400 MG / phenylephrine HCl 10 MG Oral Tablet [PSN] · guaifenesin 400 MG / phenylephrine hydrochloride 10 MG Oral Tablet [SCD] | 2 | 3 | DRUG FACTS | 20241218 |
| b6c0362f-86ca-4f08-ba53-800c6df2c025 | guaiFENesin 400 MG / phenylephrine HCl 10 MG Oral Tablet [PSN] · guaifenesin 400 MG / phenylephrine hydrochloride 10 MG Oral Tablet [SCD] | 2 | 3 | DRUG FACTS | 20241218 |
| 7420e5ad-f818-4425-bd72-4014f313ba5a | guaiFENesin 400 MG / phenylephrine HCl 10 MG Oral Tablet [PSN] · guaifenesin 400 MG / phenylephrine hydrochloride 10 MG Oral Tablet [SCD] | 2 | 3 | DRUG FACTS | 20221229 |
| a2cf1318-d2c1-4335-97d0-98e752e5649d | guaiFENesin 400 MG / phenylephrine HCl 10 MG Oral Tablet [PSN] · guaifenesin 400 MG / phenylephrine hydrochloride 10 MG Oral Tablet [SCD] | 2 | 2 | Major 44-542 | 20210225 |
| d4b5c614-2d2f-4bd5-ad5b-44738d34941c | guaiFENesin 400 MG / phenylephrine HCl 10 MG Oral Tablet [PSN] · guaifenesin 400 MG / phenylephrine hydrochloride 10 MG Oral Tablet [SCD] | 2 | 2 | DRUG FACTS | 20151009 |
| cad73d08-a439-446f-aaa9-d1fd18ec1e54 | guaiFENesin 400 MG / phenylephrine HCl 10 MG Oral Tablet [PSN] · guaifenesin 400 MG / phenylephrine hydrochloride 10 MG Oral Tablet [SCD] | 2 | 1 | Drug Facts | 20180501 |
| ab7ca98a-e6ca-4f91-a199-e69b9c86b4e2 | guaiFENesin 400 MG / phenylephrine HCl 10 MG Oral Tablet [PSN] · guaifenesin 400 MG / phenylephrine hydrochloride 10 MG Oral Tablet [SCD] | 2 | 1 | DRUG FACTS | 20140926 |
| 5667fc64-88b5-4caa-87bb-f08808a1d35c | guaiFENesin 400 MG / phenylephrine HCl 10 MG Oral Tablet [PSN] · guaifenesin 400 MG / phenylephrine hydrochloride 10 MG Oral Tablet [SCD] | 2 | 1 | DRUG FACTS | 20140925 |
| 18b3ac1b-408d-4658-8fc9-68ee1f05cefd | guaiFENesin 400 MG / phenylephrine HCl 10 MG Oral Tablet [PSN] · guaifenesin 400 MG / phenylephrine hydrochloride 10 MG Oral Tablet [SCD] | 2 | 1 | DRUG FACTS | 20140404 |
| 402c38c8-5fde-4d71-b677-39d31865e294 | guaiFENesin 400 MG / phenylephrine HCl 10 MG Oral Tablet [PSN] · guaifenesin 400 MG / phenylephrine hydrochloride 10 MG Oral Tablet [SCD] | 2 | 1 | DRUG FACTS | 20140404 |
| 10874e99-e7fa-4994-9af8-7e203262b1cc | guaiFENesin 400 MG / phenylephrine HCl 10 MG Oral Tablet [PSN] · guaifenesin 400 MG / phenylephrine hydrochloride 10 MG Oral Tablet [SCD] | 2 | 1 | DRUG FACTS | 20130702 |
| f6794885-a3ab-40a9-9e9a-5665faf7c4da | guaiFENesin 400 MG / phenylephrine HCl 10 MG Oral Tablet [PSN] · guaifenesin 400 MG / phenylephrine hydrochloride 10 MG Oral Tablet [SCD] | 2 | 1 | DRUG FACTS | 20110126 |
| d917dd8c-ee34-4ccc-b192-cafafc73ce22 | guaiFENesin 400 MG / phenylephrine HCl 10 MG Oral Tablet [PSN] · guaifenesin 400 MG / phenylephrine hydrochloride 10 MG Oral Tablet [SCD] | 2 | 1 | DRUG FACTS | 20101220 |
Recently Linked DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| 2fb83580-7fe1-41a5-abf6-0dc25520f260 | DRUG FACTS | Rugby Laboratories | Reese Pharmaceutical | Pharbest | 20261002 |
| b9129c7b-c869-436f-ab95-269610ef2d9f | Leader 44-542 | Cardinal Health 110, LLC. DBA Leader | LNK International, Inc. | 20261001 |
| cb1c1922-5dc6-520d-e77e-e951726d9701 | Walgreens 44-542 | Walgreen Company | LNK International, Inc. | 20260804 |
| 3429aedc-e83d-498a-bfca-03aaf5847b3b | DRUG FACTS | Strategic Sourcing Services LLC | Reese Pharmaceutical Co | 20260115 |
| b9129c7b-c869-436f-ab95-269610ef2d9f | Leader 44-542 | Cardinal Health 110, LLC. DBA Leader | LNK International, Inc. | 20251009 |
| cb1c1922-5dc6-520d-e77e-e951726d9701 | Walgreens 44-542 | Walgreen Company | LNK International, Inc. | 20250818 |
| e459bb83-b1d6-42fc-aa46-99ad117e6144 | Drug Facts | Ulai Health LLC | 20250120 |
| 2fb83580-7fe1-41a5-abf6-0dc25520f260 | DRUG FACTS | Rugby Laboratories | Reese Pharmaceutical Co | 20241218 |
| f94ae469-4c79-4ce9-9a3d-3bdc645be6d9 | DRUG FACTS | Strategic Sourcing Services LLC | Reese Pharmaceutical Co | 20241218 |
| 63932e68-b09d-4500-bc1d-cfb2c267df1c | DRUG FACTS | AmerisourceBergen Drug Corp | Reese Pharmaceutical Co | Pharbest | 20241218 |
| b6c0362f-86ca-4f08-ba53-800c6df2c025 | DRUG FACTS | TOPCO ASSOCIATES LLC | Reese Pharmaceutical Co | 20241218 |
| a49020e8-739e-47ec-8141-e866479a3ab3 | DRUG FACTS | CVS Pharmacy, Inc. | Reese Pharmaceutical Co | 20241218 |
| 5fb7ceb4-97da-4aa5-baa4-9eb2778ee2f6 | DRUG FACTS | Valu Merch | Reese Pharmaceutical Co | Pharbest | 20241217 |
| b9129c7b-c869-436f-ab95-269610ef2d9f | Leader 44-542 | Cardinal Health 110, LLC. DBA Leader | LNK International, Inc. | 20241213 |
| 2b79565f-5038-4cc4-ad75-2c6692411405 | Major 44-542 | Proficient Rx LP | 20231001 |
| 7f8f58a7-803b-4d62-bd8b-f05ab559a45f | Major 44-542 | Major Pharmaceuticals | LNK International, Inc. | 20230309 |
| 7420e5ad-f818-4425-bd72-4014f313ba5a | DRUG FACTS | AmerisourceBergen Drug Corp | Reese Pharmaceutical Co | Pharbest | 20221229 |
| 31842dc3-1f99-405a-8496-2946a0c3817a | Premier Value 44-542 | Chain Drug Consortium | LNK International, Inc. | 20221221 |
| a2cf1318-d2c1-4335-97d0-98e752e5649d | Major 44-542 | Preferred Pharmaceuticals Inc. | 20210225 |
| 31257238-a0b0-4f2c-98ea-c24b8a6dc30a | Major 44-542 | Preferred Pharmaceuticals, Inc. | 20191101 |
| ceebbf6c-fb90-41fa-a3c5-170600319f48 | Signature Care 44-542 | Better Living Brands, LLC | LNK International, Inc. | 20190717 |
| cad73d08-a439-446f-aaa9-d1fd18ec1e54 | Drug Facts | Pharbest Pharmaceuticals, Inc. | 20180501 |
| d4b5c614-2d2f-4bd5-ad5b-44738d34941c | DRUG FACTS | Chain Drug Consortium, LLC | Reese Pharmaceutical Co | 20151009 |
| 0b2a2dac-7e5c-411b-bedb-87141a11d93d | Drug Facts | Allegiant Health | 20141223 |
| ab7ca98a-e6ca-4f91-a199-e69b9c86b4e2 | DRUG FACTS | Select Brand Distributors | Reese Pharmaceutical Co | 20140926 |
| 5667fc64-88b5-4caa-87bb-f08808a1d35c | DRUG FACTS | REESE PHARMACEUTICAL CO. | 20140925 |
| 18b3ac1b-408d-4658-8fc9-68ee1f05cefd | DRUG FACTS | Chain Drug Marketing Association | Reese Pharmaceutical Co | 20140404 |
| 402c38c8-5fde-4d71-b677-39d31865e294 | DRUG FACTS | Reese Pharmaceutical Co | 20140404 |
| 10874e99-e7fa-4994-9af8-7e203262b1cc | DRUG FACTS | Shopko | Reese Pharmaceutical Co | 20130702 |
| 651d2c7e-02b5-44f9-b7a8-4025b19f21dc | National Council for Prescription Drug Programs | 20130401 | |
| 3087814c-491f-47f6-b0b1-7598f8e43884 | National Council for Prescription Drug Programs | 20130303 | |
| 79753d0c-44ed-4cb4-9568-1c1c7aaa9cea | National Council for Prescription Drug Programs | 20130213 | |
| ad7a60ea-b709-45ac-af95-99840eed41eb | DRUG FACTS | Kinray | Reese Pharmaceutical Co | 20130115 |
| 558701af-7a29-47c6-b734-3b0fa5bca015 | National Council for Prescription Drug Programs | 20120724 | |
| b8520e16-1cb1-44f3-bea5-84ebdc878385 | National Council for Prescription Drug Programs | 20120724 | |
| 2d49e37e-657f-4757-bffa-e4df2576b9c6 | National Council for Prescription Drug Programs | 20120724 | |
| 2196361d-8311-42c2-84ee-d81aae2e40b9 | National Council for Prescription Drug Programs | 20120724 | |
| 9758424c-e3f5-40f8-9344-8387976aa38d | National Council for Prescription Drug Programs | 20120724 | |
| 08233978-db81-48a9-a4e6-5b5b4f19e420 | Maxiphen | MCR American Pharmaceuticals, Inc. | TG United Inc | 20110505 |
| 171fe7a3-bdc4-44d3-a778-f600ad167f1b | DRUG FACTS | Cardinal Health | Reese Pharmaceutical Co | 20110126 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | C01CA | Adrenergic and dopaminergic agents | ATC1-4 | phenylephrine | |
| ATC | R05CA | Expectorants | ATC1-4 | guaifenesin | |
| ATC | C05AX | Other agents for treatment of hemorrhoids and anal fissures for topical use | ATC1-4 | phenylephrine | |
| ATC | R01BA | Sympathomimetics | ATC1-4 | phenylephrine | |
| ATC | S01FB | Sympathomimetics excl. antiglaucoma preparations | ATC1-4 | phenylephrine | |
| ATC | S01GA | Sympathomimetics used as decongestants | ATC1-4 | phenylephrine | |
| ATC | R01AB | Sympathomimetics, combinations excl. corticosteroids | ATC1-4 | phenylephrine | |
| ATC | R01AA | Sympathomimetics, plain | ATC1-4 | phenylephrine | |
| FDASPL | N0000186105 | alpha-1 Adrenergic Agonist | EPC | has_epc | phenylephrine |
| FDASPL | N0000193956 | Expectorant | EPC | has_epc | guaifenesin |
| MEDRT | D006140 | Guaifenesin | CHEM | has_ingredient | guaifenesin |
| MEDRT | D010656 | Phenylephrine | CHEM | has_ingredient | phenylephrine |
| MEDRT | D010656 | Phenylephrine | CHEM | has_ingredient | phenylephrine hydrochloride |
| MEDRT | D013447 | Sulfites | CHEM | ci_chemclass | phenylephrine |
| MEDRT | D013447 | Sulfites | CHEM | ci_chemclass | phenylephrine hydrochloride |
| MEDRT | D001991 | Bronchitis | DISEASE | may_treat | guaifenesin |
| MEDRT | D003139 | Common Cold | DISEASE | may_treat | guaifenesin |
| MEDRT | D003371 | Cough | DISEASE | may_treat | guaifenesin |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | guaifenesin |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | phenylephrine hydrochloride |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | phenylephrine |
| MEDRT | D005401 | Fissure in Ano | DISEASE | may_treat | phenylephrine |
| MEDRT | D005401 | Fissure in Ano | DISEASE | may_treat | phenylephrine hydrochloride |
| MEDRT | D005902 | Glaucoma, Open-Angle | DISEASE | may_treat | phenylephrine |
| MEDRT | D005902 | Glaucoma, Open-Angle | DISEASE | may_treat | phenylephrine hydrochloride |
| MEDRT | D006484 | Hemorrhoids | DISEASE | may_treat | phenylephrine hydrochloride |
| MEDRT | D006484 | Hemorrhoids | DISEASE | may_treat | phenylephrine |
| MEDRT | D006973 | Hypertension | DISEASE | ci_with | phenylephrine hydrochloride |
| MEDRT | D006973 | Hypertension | DISEASE | ci_with | phenylephrine |
| MEDRT | D007022 | Hypotension | DISEASE | may_treat | phenylephrine |
| MEDRT | D007022 | Hypotension | DISEASE | may_treat | phenylephrine hydrochloride |
| MEDRT | D007827 | Laryngitis | DISEASE | may_treat | guaifenesin |
| MEDRT | D015878 | Mydriasis | DISEASE | induces | phenylephrine hydrochloride |
| MEDRT | D015878 | Mydriasis | DISEASE | induces | phenylephrine |
| MEDRT | D010612 | Pharyngitis | DISEASE | may_treat | guaifenesin |
| MEDRT | D011538 | Pruritus Ani | DISEASE | may_treat | phenylephrine |
| MEDRT | D011538 | Pruritus Ani | DISEASE | may_treat | phenylephrine hydrochloride |
| MEDRT | D012221 | Rhinitis, Allergic, Perennial | DISEASE | may_treat | guaifenesin |
| MEDRT | D012223 | Rhinitis, Vasomotor | DISEASE | may_treat | phenylephrine |
| MEDRT | D012223 | Rhinitis, Vasomotor | DISEASE | may_treat | phenylephrine hydrochloride |
| MEDRT | D012772 | Shock, Septic | DISEASE | may_treat | phenylephrine |
| MEDRT | D012772 | Shock, Septic | DISEASE | may_treat | phenylephrine hydrochloride |
| MEDRT | D012852 | Sinusitis | DISEASE | may_treat | guaifenesin |
| MEDRT | D013617 | Tachycardia, Supraventricular | DISEASE | may_treat | phenylephrine hydrochloride |
| MEDRT | D013617 | Tachycardia, Supraventricular | DISEASE | may_treat | phenylephrine |
| MEDRT | D017180 | Tachycardia, Ventricular | DISEASE | ci_with | phenylephrine hydrochloride |
| MEDRT | D017180 | Tachycardia, Ventricular | DISEASE | ci_with | phenylephrine |
| MEDRT | D014917 | Whooping Cough | DISEASE | may_treat | guaifenesin |
| MEDRT | N0000000209 | Adrenergic alpha-Agonists | MOA | has_moa | phenylephrine hydrochloride |
| MEDRT | N0000000209 | Adrenergic alpha-Agonists | MOA | has_moa | phenylephrine |
| MEDRT | N0000008371 | Conjunctival Arterial Vasoconstriction | PE | has_pe | phenylephrine |
| MEDRT | N0000008371 | Conjunctival Arterial Vasoconstriction | PE | has_pe | phenylephrine hydrochloride |
| MEDRT | N0000008896 | Decreased Nasal and Sinus Secretions | PE | has_pe | phenylephrine |
| MEDRT | N0000008896 | Decreased Nasal and Sinus Secretions | PE | has_pe | phenylephrine hydrochloride |
| MEDRT | N0000008867 | Decreased Respiratory Secretion Viscosity | PE | has_pe | guaifenesin |
| MEDRT | N0000009560 | Increased Respiratory Secretions | PE | has_pe | guaifenesin |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 400 MG / 10 MG |
| ATTRIBUTES | GENERAL_CARDINALITY | MULTI |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 0 |
| CODES | VUID | 4030591 |
| NAMES | Prescribable Synonym | guaiFENesin 400 MG / phenylephrine HCl 10 MG Oral Tablet |
| NAMES | Tallman Synonym | guaiFENesin 400 MG / phenylephrine hydrochloride 10 MG Oral Tablet |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Micromedex RED BOOK |
| SOURCES | Source | Multum MediSource Lexicon |
| SOURCES | Source | National Drug Data File Plus Source Vocabulary |
| SOURCES | Source | Veterans Health Administration National Drug File |